Resmed (RMD) Operating Leases (2019 - 2025)
Resmed (RMD) has disclosed Operating Leases for 6 consecutive years, with $154.1 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Operating Leases rose 10.76% year-over-year to $154.1 million, compared with a TTM value of $154.1 million through Dec 2025, up 10.76%, and an annual FY2025 reading of $153.0 million, up 8.18% over the prior year.
- Operating Leases was $154.1 million for Q4 2025 at Resmed, up from $147.8 million in the prior quarter.
- Across five years, Operating Leases topped out at $154.1 million in Q4 2025 and bottomed at $112.4 million in Q3 2023.
- Average Operating Leases over 5 years is $130.1 million, with a median of $130.1 million recorded in 2021.
- The sharpest move saw Operating Leases decreased 12.43% in 2022, then rose 28.49% in 2024.
- Year by year, Operating Leases stood at $133.0 million in 2021, then dropped by 12.43% to $116.4 million in 2022, then grew by 20.79% to $140.6 million in 2023, then dropped by 1.06% to $139.2 million in 2024, then increased by 10.76% to $154.1 million in 2025.
- Business Quant data shows Operating Leases for RMD at $154.1 million in Q4 2025, $147.8 million in Q3 2025, and $153.0 million in Q2 2025.